Theralase appoints Cordoba as Therapeutic Division GM

March 21, 2011
Toronto, ON, Canada--Theralase announced that Jorge Córdoba has been appointed as general manager - Therapeutic Division for its therapeutic medical laser products.

Toronto, ON, Canada--Theralase Technologies (TSXV: TLT) announced that effective immediately, Jorge Córdoba has been appointed as general manager - Therapeutic Division for Theralase’s line of proprietary therapeutic medical laser products. Córdoba, reporting to Roger Dumoulin-White, president and CEO, will have general management responsibilities over the sales, marketing, production, clinical services and regulatory affairs departments.

Córdoba has over 16 years of experience in leading numerous high-technology manufacturing companies to success, providing general management expertise in local and international sales, marketing, production, operations and regulatory affairs. His last position was as director of operations for a $17 million aerospace organization turnaround situation, in which Córdoba, through a number of different initiatives, achieved an increase in productivity of over 400% in less than 2 years. Prior to that, Córdoba successfully launched a 250,000 square foot, $40 million facility for manufacturing high precision assemblies for a division of Magna Inc. In an earlier position, he was the sales and marketing manager for a high tech equipment manufacturer, responsible for sales in excess of $10 million annually.

“I am excited to be part of such a world-class medical organization as Theralase. Under the direction of Roger Dumoulin-White, Theralase has systematically developed valuable intellectual property in the medical laser space and in my estimation is now positioned to rapidly execute on its growth strategy,” said Córdoba. “I accepted the position because Theralase has such wonderful upside, attracting a dedicated team of professionals able to take this intellectual property to the next level and dramatically increase its revenue over the next few years. I look forward to following in Roger’s footsteps to dramatically grow the therapeutic division of the Company.”

Córdoba obtained a Master’s of Business from the Ivey School of Business, University of Western Ontario, London, Ontario in 2005, a Master’s of Science in Advanced Manufacturing Technology from the University of Manchester, Manchester, England in 1993 and a Bachelor of Mechanical-Electrical Engineering from the National University, Mexico City, Mexico in 1989.

SOURCE: Theralase;

Posted by:Gail OvertonSubscribe now to Laser Focus World magazine; It’s free! Follow us on TwitterFollow OptoIQ on your iPhone. Download the free App here

Sponsored Recommendations

Request a free Micro 3D Printed sample part

April 11, 2024
The best way to understand the part quality we can achieve is by seeing it first-hand. Request a free 3D printed high-precision sample part.

How to Tune Servo Systems: The Basics

April 10, 2024
Learn how to tune a servo system using frequency-based tools to meet system specifications by watching our webinar!

Motion Scan and Data Collection Methods for Electro-Optic System Testing

April 10, 2024
Learn how different scanning patterns and approaches can be used in measuring an electro-optic sensor performance, by reading our whitepaper here!

How Precision Motion Systems are Shaping the Future of Semiconductor Manufacturing

March 28, 2024
This article highlights the pivotal role precision motion systems play in supporting the latest semiconductor manufacturing trends.

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!